文献速递前列腺癌

免疫内容与基因组分类器的转录组交互预测高级别前列腺癌致死结局

Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer.
PubMed 文献 · Eur Urol · 2020-12-07

研究利用8071例肿瘤组织转录组数据,基于免疫内容评分(ICS)与Decipher基因组分类器构建四种免疫基因组亚型。在GG-45患者中,ICSHigh/DecipherHigh亚型与基因组放射敏感性增加相关,且多变量模型显示其远处转移和前列腺癌特异性死亡风险显著高于ICSLow/DecipherLow。

要点

  • GG-45前列腺癌中ICSHigh/DecipherHigh亚型比例最高。
  • 该亚型与基因组放射敏感性增加相关。
  • 该亚型远处转移和PCa特异性死亡风险显著升高。

核心结论

  • ICS与Decipher的协同交互可识别GG-45前列腺癌中最致命的亚组。

研究设计与样本

  • 利用8071例肿瘤组织全转录组数据(6071例前列腺切除标本和2000例初治活检样本)推导四种免疫基因组亚型。
  • 在GG-45患者样本(n=1420)中进一步分析亚型特征。
  • 多变量模型纳入335例样本评估结局风险。

主要发现

  • GG-45样本中ICSHigh/DecipherHigh亚型比例最高。
  • ICSHigh/DecipherHigh亚型与基因组放射敏感性增加相关。
  • 多变量模型中,ICSHigh/DecipherHigh亚型远处转移风险显著高于ICSLow/DecipherLow(HR=5.41;95%CI 2.76-10.6;p≤0.0001)。
  • ICSHigh/DecipherHigh亚型PCa特异性死亡风险显著高于ICSLow/DecipherLow(HR=10.6;95%CI 4.18-26.94;p≤0.0001)。

关键数值与推荐

  • ICSHigh/DecipherHigh亚型远处转移HR=5.41(95%CI 2.76-10.6;p≤0.0001)。
  • ICSHigh/DecipherHigh亚型PCa特异性死亡HR=10.6(95%CI 4.18-26.94;p≤0.0001)。

临床怎么用

  • ICS与Decipher联合分型有助于识别GG-45前列腺癌中可能从免疫-放疗联合模式获益的高危患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Grade group 4 and 5 (GG-45) prostate cancer (PCa) patients are at the highest risk of lethal outcomes, yet lack genomic risk stratification for prognosis and treatment selection. Here, we assess whether transcriptomic interactions between tumor immune content score (ICS) and the Decipher genomic classifier can identify most lethal subsets of GG-45 PCa. We utilized whole transcriptome data from 8071 tumor tissue (6071 prostatectomy and 2000 treatment-naïve biopsy samples) to derive four immunogenomic subtypes using ICS and Decipher. When compared across all grade groups, GG-45 samples had the highest proportion of most aggressive subtype-ICSHigh/DecipherHigh. Subsequent analyses within the GG-45 patient samples (n = 1420) revealed that the ICSHigh/DecipherHigh subtype was associated with increased genomic radiosensitivity. Additionally, in a multivariable model (n = 335), ICSHigh/DecipherHigh subtype had a significantly higher risk of distant metastasis (hazard ratio [HR] = 5.41; 95% confidence interval [CI], 2.76-10.6; p ≤ 0.0001) and PCa-specific mortality (HR = 10.6; 95% CI, 4.18-26.94; p ≤ 0.0001) as compared with ICSLow/DecipherLow. The novel immunogenomic subtypes establish a very strong synergistic interaction between ICS and Decipher in identifying GG-45 patients who experience the most lethal outcomes. PATIENT SUMMARY: In this analysis, we identified a novel interaction between the total immune content of prostate tumors and genomic classifier to identify the most lethal subset of patients with grade groups 4 and 5. Our results will aid in the subtyping of aggressive prostate cancer patients who may benefit from combined immune-radiotherapy modalities.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Yamoah K, Awasthi S, Mahal BA, et al. Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer. Eur Urol. 2020. PMID: 33303244. doi:10.1016/j.eururo.2020.11.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。